XML 28 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2018   74,697,526      
Balance at Dec. 31, 2018 $ 197,221 $ 75 $ 419,456 $ (220,276) $ (2,034)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 5,290   5,290    
Exercise of stock options (in shares)   157,334      
Exercise of stock options 703   703    
Issuance of common stock for vested restricted stock awards (in shares)   1,372,723      
Issuance of common stock for vested restricted stock awards 0 $ 2 (2)    
Restricted stock awards withheld to cover taxes (371)   (371)    
Other comprehensive income 95       95
Net income 3,462     3,462  
Balance (in shares) at Jun. 30, 2019   76,227,583      
Balance at Jun. 30, 2019 206,400 $ 77 425,076 (216,814) (1,939)
Balance (in shares) at Mar. 31, 2019   75,270,035      
Balance at Mar. 31, 2019 201,227 $ 76 422,472 (219,018) (2,303)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 2,865   2,865    
Exercise of stock options (in shares)   5,597      
Exercise of stock options 23   23    
Issuance of common stock for vested restricted stock awards (in shares)   951,951      
Issuance of common stock for vested restricted stock awards 0 $ 1 (1)    
Restricted stock awards withheld to cover taxes (283)   (283)    
Other comprehensive income 364       364
Net income 2,204     2,204  
Balance (in shares) at Jun. 30, 2019   76,227,583      
Balance at Jun. 30, 2019 206,400 $ 77 425,076 (216,814) (1,939)
Increase (Decrease) in Stockholders' Equity          
Cumulative effect of new accounting principle in period of adoption | ASU 2016-13 (159)     (159)  
Balance (in shares) at Dec. 31, 2019   70,756,013      
Balance at Dec. 31, 2019 197,240 $ 71 430,959 (231,441) (2,349)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense $ 6,035   6,035    
Exercise of stock options (in shares) 506,105 506,105      
Exercise of stock options $ 1,987   1,987    
Issuance of common stock for vested restricted stock awards (in shares)   1,543,388      
Issuance of common stock for vested restricted stock awards 2 $ 2      
Restricted stock awards withheld to cover taxes (636)   (636)    
Repurchase and retirement of common stock (in shares)   (12,935)      
Repurchase and retirement of common stock (65)     (65)  
Other comprehensive income 666       666
Net income 7,971     7,971  
Balance (in shares) at Jun. 30, 2020   72,792,571      
Balance at Jun. 30, 2020 213,041 $ 73 438,345 (223,694) (1,683)
Balance (in shares) at Mar. 31, 2020   71,185,492      
Balance at Mar. 31, 2020 198,089 $ 71 434,622 (234,073) (2,531)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 2,850   2,850    
Exercise of stock options (in shares)   343,264      
Exercise of stock options 1,423   1,423    
Issuance of common stock for vested restricted stock awards (in shares)   1,263,815      
Issuance of common stock for vested restricted stock awards 2 $ 2      
Restricted stock awards withheld to cover taxes (550)   (550)    
Other comprehensive income 848       848
Net income 10,379     10,379  
Balance (in shares) at Jun. 30, 2020   72,792,571      
Balance at Jun. 30, 2020 $ 213,041 $ 73 $ 438,345 $ (223,694) $ (1,683)